Research programme: oral anti-infective vaccine - Kobe University/Morishita Jintan
Latest Information Update: 11 Jun 2012
At a glance
- Originator Kobe University
- Developer Kobe University; Morishita Jintan
- Class Vaccines
- Mechanism of Action Immunostimulants
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Phase Unknown Infections
Most Recent Events
- 16 May 2012 Investigation in Infections in Japan (PO)